PharmaShots | Incisive News in 3 Shots

Subscribe Now

Global Blood Therapeutics

GBT Reports Initiation of the P-II/III Study of GBT601 for the Treatment of Sickle Cell Disease

GBT Reports Initiation of the P-II/III Study of GBT601 for the Treatment of Sickle Cell Disease

June 30, 2022

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us